Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, FM Brunkhorst, A Buzgau, AC Cheng, MA Detry… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
[PDF][PDF] Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
…, D Thomas, C Koller, W Wierda, MA Detry… - Journal of clinical …, 2005 - academia.edu
Purpose Fludarabine and cyclophosphamide (FC), which are active in treatment of chronic
lymphocytic leukemia (CLL), are synergistic with the monoclonal antibody rituximab in vitro in …
lymphocytic leukemia (CLL), are synergistic with the monoclonal antibody rituximab in vitro in …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …
…, MG Patel, D Richards, N Berry, MA Detry… - The Lancet, 2021 - thelancet.com
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
African American men and women's attitude toward mental illness, perceptions of stigma, and preferred coping behaviors
EC Ward, JC Wiltshire, MA Detry, RL Brown - Nursing research, 2013 - journals.lww.com
Background: Although research focused on African Americans with mental illness has been
increasing, few researchers have addressed gender and age differences in beliefs, attitudes…
increasing, few researchers have addressed gender and age differences in beliefs, attitudes…
Micropapillary bladder cancer: a review of the University of Texas MD Anderson Cancer Center experience with 100 consecutive patients
…, AO Siefker‐Radtke, P Tamboli, MA Detry… - Cancer, 2007 - Wiley Online Library
BACKGROUND Micropapillary bladder carcinoma is a rare variant of urothelial carcinoma.
To improve understanding of this disease, the authors performed a retrospective review of …
To improve understanding of this disease, the authors performed a retrospective review of …
Dietary Intake of Isothiocyanates: Evidence of a Joint Effect with Glutathione S-Transferase Polymorphisms in Lung Cancer Risk
MR Spitz, CM Duphorne, MA Detry, PC Pillow… - … Biomarkers & Prevention, 2000 - AACR
Isothiocyanates (ITCs) are nonnutrient compounds in cruciferous vegetables with
anticarcinogenic properties. One proposed mechanism for their protective action is through down-…
anticarcinogenic properties. One proposed mechanism for their protective action is through down-…
Analyzing repeated measurements using mixed models
MA Detry, Y Ma - Jama, 2016 - jamanetwork.com
Longitudinal studies often include multiple, repeated measurements of each patient’s status
or outcome to assess differences in outcomes or in the rate of recovery or decline over time. …
or outcome to assess differences in outcomes or in the rate of recovery or decline over time. …
Effect of P2Y12 inhibitors on survival free of organ support among non–critically ill hospitalized patients with COVID-19: a randomized clinical trial
…, S Bula, M Nelson, C Daelemans, L Paraz, MA Detry… - Jama, 2022 - jamanetwork.com
Importance Platelets represent a potential therapeutic target for improved clinical outcomes
in patients with COVID-19. Objective To evaluate the benefits and risks of adding a P2Y12 …
in patients with COVID-19. Objective To evaluate the benefits and risks of adding a P2Y12 …
The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma
…, DA Swanson, RE Millikan, MA Detry… - The Journal of …, 2006 - auajournals.org
Purpose : Micropapillary bladder carcinoma is a rare variant of UC. Due to paucity of data
regarding treatment outcomes, patients with nonmuscle invasive micropapillary UC often …
regarding treatment outcomes, patients with nonmuscle invasive micropapillary UC often …